Steininger, Lisa
Chromy, David
Bauer, David
Simbrunner, Benedikt
Binter, Teresa
Schwabl, Philipp
Schmidbauer, Caroline
Trauner, Michael
Gschwantler, Michael
Mandorfer, Mattias
Reiberger, Thomas http://orcid.org/0000-0002-4590-3583
Funding for this research was provided by:
AbbVie Deutschland
Medical University of Vienna
Article History
Received: 21 May 2020
Accepted: 27 November 2020
First Online: 22 December 2020
Compliance with ethical guidelines
:
: L. Steininger received travel support from AbbVie. D. Chromy served as a speaker and/or consultant and/or advisory board member for AbbVie, Gilead, and MSD, and received travel support from AbbVie, MSD, ViiV Healthcare and Gilead. D. Bauer received travel support from AbbVie and Gilead. B. Simbrunner received travel support from AbbVie and Gilead. T. Binter has nothing to disclose. P. Schwabl received speaker fees from Bristol-Myers Squibb and Boehringer-Ingelheim, consulting fees from PharmaIN, and travel support from Falk. C. Schmidbauer received travel support from AbbVie, Gilead and Gebro. M. Trauner received grant support from Cymabay, Falk, Gilead, Intercept, MSD, and Takeda, fees for consulting from AbbVie, Gilead, Intercept, Janssen, and MSD and Regulus, speaker fees from Falk, Gilead, and MSD, as well as travel support from AbbVie and Gilead. M. Gschwantler received grants from AbbVie, Gilead, MSD; speaker fees from AbbVie, Gilead, MSD, Janssen, Roche, Intercept; consulting/advisory board fees from AbbVie, Gilead, MSD, Janssen, Roche, Intercept. M. Mandorfer served as a speaker and/or consultant and/or advisory board member for AbbVie, Bristol-Myers Squibb, Collective Acumen, Gilead, as well as W. L. Gore & Associates, and has received travel support from AbbVie, Bristol-Myers Squibb, as well as Gilead. T. Reiberger received grant support from AbbVie, Boehringer-Ingelheim, Gilead, MSD, Philips Healthcare, Gore; speaker fees from AbbVie, Gilead, Gore, Intercept, Roche, MSD; consulting/advisory board fees from AbbVie, Bayer, Boehringer-Ingelheim, Gilead, Intercept, MSD, Siemens; and travel support from Boehringer-Ingelheim, Gilead and Roche.
: All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. The local ethics committee of the Medical University of Vienna approved the study (EC number: 1968/2018). Informed consent was obtained from all individual participants included in the study.